Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention

Documenti analoghi

• Development and validation of a Bayesian index for predicting major adverse cardiac events with percutaneous transluminal coronary angioplasty
  di: de Belder, A J, et al.
  Pubblicazione: (2001)
• Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England
  di: Grayson, A D, et al.
  Pubblicazione: (2006)
• Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release
  di: Brull, D J, et al.
  Pubblicazione: (2002)
• Hallucinations as an adverse effect of angiotensin converting enzyme inhibition.
  di: Haffner, C. A., et al.
  Pubblicazione: (1993)
• Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
  di: Meng, Long, et al.
  Pubblicazione: (2021)